跳至主要内容
临床试验/NCT04445571
NCT04445571招募中不适用

Surfactant Administration by Insure or Thin Catheter

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2021年5月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
160
试验地点
2
主要终点
Mechanical ventilation

研究概览

简要总结

This trial evaluates the efficacy and safety of surfactant administration with thin catheter technique together with analgesic premedication in comparison with the established INSURE-strategy. It will provide valuable knowledge to improve clinical methodology and enhance lung protective treatment strategies for preterm infants.

详细描述

To compare two approaches for surfactant administration during CPAP in preterm infants, the INSURE and the LISA technique, using premedication intubation protocols, and investigate aspects of safety, stress and pain, timely administration of the drug, response in oxygenation and pulmonary outcome.

Our study asks whether (P) among infants born <32 weeks' gestation with RDS (I) does surfactant administration with LISA and analgesia premedication (C) versus surfactant administration according to the INSURE protocol (O) improve oxygenation and reduce the rate of respiratory failure and need for intubation and mechanical ventilation (T) within 48 hours of the procedure

Primary outcomes:

  1. Positive effect: Oxygenation measured as arterial to alveolar ratio (a/A ratio) at 24 hours post-procedure.
  2. Negative effect: Need for mechanical ventilation (MV) within 48 hours post-procedure.

Safety outcomes:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
— 至 2 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Infants born before 32 completed weeks of gestation on CPAP, with clinical and radiological signs of RDS and need for surfactant treatment.

排除标准

  • Infants requiring surfactant as part of delivery room resuscitation are not eligible.
  • Infants will be excluded from the final analysis if they have a congenital abnormality or condition that might have an adverse effect on breathing or ventilation, including: congenital diaphragmatic hernia; tracheo-oesophageal fistula or cyanotic heart disease.

结局指标

主要结局

Mechanical ventilation

时间窗: 48 hours post-procedure

Need for intubation and mechanical ventilation (MV)

Oxygenation

时间窗: 24 hours post-procedure

Arterial to alveolar ratio (a/A ratio)

次要结局

  • Length of stay(Discharge)
  • Mortality(Discharge)
  • Duration of ventilatory support(Discharge)
  • Complications(Discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kajsa Bohlin

MD, PhD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验